A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

October 21, 2025

Primary Completion Date

February 21, 2027

Study Completion Date

May 21, 2027

Conditions

Diabetic Foot Ulcer (DFU)Venous Leg Ulcer (VLU)Pressure Ulcer

Interventions

BIOLOGICAL

DermaBind TL

Full-Thickness Dehydrated Placental Allograft

All Listed Sponsors

lead

HealthTech Wound Care

INDUSTRY

NCT07172893 - A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL | Biotech Hunter | Biotech Hunter